Assignee
VOLANT HOLDINGS GMBH
CH·4 granted patents·6 pending applications·11 citations·filing 2015–2018
Top patents by PatentIndex Score
10 records- 0188US10624913B2Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereofVOLANT HOLDINGS GMBH·Filed 2018·Granted Apr 21, 2020·3 cites·20 claims
- 0286US9443060B2Method and system to provide personalized pharmaceutical compositions and dosagesVOLANT HOLDINGS GMBH·Filed 2015·Granted Sep 13, 2016·4 cites·10 claims
- 0381US9730951B2Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infectionVOLANT HOLDINGS GMBH·Filed 2016·Granted Aug 15, 2017·3 cites·39 claims
- 0474US10245277B2Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infectionVOLANT HOLDINGS GMBH·Filed 2017·Granted Apr 2, 2019·1 cites·18 claims
- 0561US2019298804A1Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systemsVOLANT HOLDINGS GMBH·Filed 2018·Application pending·0 cites
- 0654US2018099001A1Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereofVOLANT HOLDINGS GMBH·Filed 2017·Application pending·0 cites
- 0752US2017007631A1Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2DVOLANT HOLDINGS GMBH·Filed 2016·Application pending·0 cites
- 0848US2019262367A1Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetesVOLANT HOLDINGS GMBH·Filed 2018·Application pending·0 cites
- 0944US2018369177A1Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, pre-diabetic symptoms, insulin resistance and related disease states and conditionsVOLANT HOLDINGS GMBH·Filed 2017·Application pending·0 cites
- 1043US2017014436A1Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetes.VOLANT HOLDINGS GMBH·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →